Literature DB >> 11356981

PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.

M Ikeda1, A Ikeda, R Longnecker.   

Abstract

Latent membrane protein 2A (LMP2A) is expressed in latent Epstein-Barr virus (EBV) infection. We have demonstrated that Nedd4 family ubiquitin-protein ligases (E3s), AIP4, WWP2/AIP2, and Nedd4, bind specifically to two PY motifs present within the LMP2A amino-terminal domain. In this study, LMP2A PY motif mutant viruses were constructed to investigate the role of the LMP2A PY motifs. AIP4 was found to specifically associate with the LMP2A PY motifs in EBV-transformed lymphoblastoid cell lines (LCLs), extending our original observation to EBV-infected cells. Mutation of both of the LMP2A PY motifs resulted in an absence of binding of AIP4 to LMP2A, which resulted in an increase in the expression of Lyn and the constitutive hyperphosphorylation of LMP2A and an unknown 120-kDa protein. In addition, there was a modest increase in the constitutive phosphorylation of Syk and an unidentified 60-kDa protein. These results indicate that the PY motifs contained within LMP2A are important in regulating phosphorylation in EBV-infected LCLs, likely through the regulation of Lyn activity by specifically targeting the degradation of Lyn by ubiquination by Nedd4 family E3s. Despite differences between PY motif mutant LCLs and wild-type LCLs, the PY motif mutants still exhibited a block in B-cell receptor (BCR) signal transduction as measured by the induction of tyrosine phosphorylation and BZLF1 expression following BCR activation. EBV-transformed LCLs with mutations in the PY motifs were not different from wild-type LCLs in serum-dependent cell growth. Protein stability of LMP1, which colocalizes with LMP2A, was not affected by the LMP2A-associated E3s.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356981      PMCID: PMC114286          DOI: 10.1128/JVI.75.12.5711-5718.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  WW- and SH3-domain interactions with Epstein-Barr virus LMP2A.

Authors:  R Longnecker; M Merchant; M E Brown; S Fruehling; J O Bickford; M Ikeda; R N Harty
Journal:  Exp Cell Res       Date:  2000-06-15       Impact factor: 3.905

3.  A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

Authors:  R Longnecker; E Kieff
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

Authors:  L Young; C Alfieri; K Hennessy; H Evans; C O'Hara; K C Anderson; J Ritz; R S Shapiro; A Rickinson; E Kieff
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

5.  Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells.

Authors:  M Biggin; M Bodescot; M Perricaudet; P Farrell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.

Authors:  S Aviel; G Winberg; M Massucci; A Ciechanover
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

7.  Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.

Authors:  R Swart; S Fruehling; R Longnecker
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

8.  An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.

Authors:  R Longnecker; B Druker; T M Roberts; E Kieff
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

9.  Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.

Authors:  G Winberg; L Matskova; F Chen; P Plant; D Rotin; G Gish; R Ingham; I Ernberg; T Pawson
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

10.  Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus.

Authors:  Peter Speck; Kimberly A Kline; Paul Cheresh; Richard Longnecker
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

View more
  28 in total

1.  Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation.

Authors:  Christopher Riling; Hari Kamadurai; Suresh Kumar; Claire E O'Leary; Kuen-Phon Wu; Erica E Manion; Mingjie Ying; Brenda A Schulman; Paula M Oliver
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

2.  An auto-regulatory loop for EBV LMP2A involves activation of Notch.

Authors:  Leah J Anderson; Richard Longnecker
Journal:  Virology       Date:  2007-11-05       Impact factor: 3.616

Review 3.  Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.

Authors:  Hiroshi Ageta; Kunihiro Tsuchida
Journal:  Cell Mol Life Sci       Date:  2019-07-30       Impact factor: 9.261

4.  Influenza virus budding does not require a functional AAA+ ATPase, VPS4.

Authors:  Rie Watanabe; Robert A Lamb
Journal:  Virus Res       Date:  2010-07-17       Impact factor: 3.303

Review 5.  Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.

Authors:  Yao Chang; Yu-Yan Lan; Jenn-Ren Hsiao; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-07

6.  Multi-transmembrane protein K15 of Kaposi's sarcoma-associated herpesvirus targets Lyn kinase in the membrane raft and induces NFAT/AP1 activities.

Authors:  Nam-Hyuk Cho; Young-Ki Choi; Joong-Kook Choi
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

7.  Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein.

Authors:  Melanie M Brinkmann; Mark Glenn; Lucille Rainbow; Arnd Kieser; Cornelia Henke-Gendo; Thomas F Schulz
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  LMP2A does not require palmitoylation to localize to buoyant complexes or for function.

Authors:  Rebecca B Katzman; Richard Longnecker
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells.

Authors:  David N Everly; Shuichi Kusano; Nancy Raab-Traub
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling.

Authors:  Masato Ikeda; Richard Longnecker
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.